Fr. 53.40

Promise Of Low Dose Naltrexone Therapy - Potential Benefits in Cancer, Autoimmune, Neurological and Infectious

English · Paperback / Softback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

Informationen zum Autor Elaine A. Moore has worked in hospital laboratories for more than 30 years, primarily in immunohematology and toxicology. She is a freelance medical writer and laboratory consultant. For more information, visit her website at www.elaine-moore.com . She lives in Sedalia, Colorado. Samantha Wilkinson is a patient advocate for multiple sclerosis and LDN. Through her website www.ldners.org she educates patients about current LDN research. She lives in Edmonds, Washington. Klappentext Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers. Zusammenfassung Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 as a safe and effective treatment for opiate and drug abuse. This book describes the history of naltrexone! including its potential therapeutic uses! its effects on the immune system! and its pharmacological properties. Inhaltsverzeichnis Table of ContentsAcknowledgments      Foreword by Yash Pal Agrawal, M.D., Ph.D.      Preface      Introduction      1. The War on Drugs-A History of Naltrexone      2. LDN in Autoimmune Diseases      3. LDN in Multiple Sclerosis      4. LDN in Neurodegenerative Disorders      5. LDN in Cancer      6. LDN in Autism Spectrum Disorders      7. LDN in Wound Healing and Infections      8. The Immune System and LDN in HIV/AIDS      9. The LDN Experience: A Patient's Guide to LDN      10. The Potential Benefits and Future of LDN      Chapter Notes      Glossary      Appendix: Clinical Trials of LDN and Related Compounds      Resources      Index      ...

Product details

Authors Elaine A Moore, Elaine A. Moore, Samantha Wilkinson
Publisher McFarland
 
Languages English
Product format Paperback / Softback
Released 01.11.2008
 
EAN 9780786437153
ISBN 978-0-7864-3715-3
Series McFarland Health Topics
McFarland Health Topics
Subjects Natural sciences, medicine, IT, technology > Medicine > Non-clinical medicine
Non-fiction book > Politics, society, business > Politics

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.